Patterns of symptom reporting during pregnancy comparing opioid maintained and control women

Journal of Addiction Medicine

Volumn 6, Issue 4, 2012, Pages 258-264

  Gordon, Andrea L ^a,b   Lopatko, Olga V ^b   Stacey, Helen ^c   Pearson, Vicki ^d   Woods, Anna ^d   Fisk, Ann ^d   White, Jason M ^a,b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^d Drug & Alcohol Services South Australia   (Australia)

Author keywords

Buprenorphine; Methadone; Opioid maintained; Pregnancy; Symptom

Indexed keywords

BUPRENORPHINE; METHADONE;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; AUSTRALIA; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FETAL WELL BEING; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MATERNAL WELFARE; PARITY; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; SMOKING; SUBSTANCE ABUSE; SYMPTOM; WITHDRAWAL SYNDROME;

ADULT; BUPRENORPHINE; CASE-CONTROL STUDIES; FEMALE; HUMANS; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; SELF REPORT; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84871220921     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e31826b299d     Document Type: Article

References (42)

1. Binder T, Vavrinkova B. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Neuro Endocrinol Lett 2008;29:80-86.
2. Crane E, Morris JK. Changes in maternal age in England and Wales- implications for Down syndrome. DSRP 2006;10:41-43.
3. Darke S, Ross J, Williamson A, Mills KL, Havard A, Teesson M. Patterns and correlates of attempted suicide by heroin users over a 3-year period: findings from the Australian treatment outcome study. Drug Alcohol Depend 2007;87:146-152.
4. Doberczak TM, Kandall SR, Friedmann P. Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecol 1993;81:936-940.
5. Dyer KR, White JM. Patterns of symptom complaints in methadone maintenance patients. Addiction 1997;92:1445-1455.
6. Finnegan LP. Treatment issues for opioid-dependent women during the perinatal period. J Psychoactive Drugs 1991;23:191-201.
7. Finnegan LP, Kandall SR. Maternal and neonatal effects of alcohol and drugs. In: Lowinson JH SR, Ruiz P SR, Millman RB, Langrod JG, eds RB. Substance Abuse. Baltimore, MD: Williams and Wilkins, 1997:513-534.
8. Fischer G, Ortner R, Rohrmeister K, et al. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction. 2006;101:275-281.
9. Glass MJ, Billington CJ, Levine AS. Opioids and food intake: distributed functional neural pathways? Neuropeptides 1999;33:360-368.
10. Godding V, Bonnier C, Fiasse L, et al. Does in utero exposure to heavy maternal smoking induce nicotine withdrawal symptoms in neonates? Pediatr Res 2004;55:645-651.
11. Gossop M. The development of a Short Opiate Withdrawal Scale (SOWS). Addict Behav 1990;15:487-490.
12. Handelsman L, Cochrane KJ, Aronson MJ, et al. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987;13:293-308.
13. Harder VS, Morral AR, Arkes J. Marijuana use and depression among adults: testing for causal associations. Addiction 2006;101:1463-1472.
14. Havard A, Teesson M, Darke S, Ross J. Depression among heroin users:12-Month outcomes from the Australian Treatment Outcome Study (ATOS). J Subst Abuse Treat 2006;30:355-362.
15. Hay JL, White JM, Bochner F, et al. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. J Pain 2009;10:316-322.
16. Henry-Edwards S, Gowing L, White J, et al. Clinical guidelines and procedures for the use of methadone in the maintenance treatment of opioid dependence. Canberra, Australia: Australian Government Department of Health and Ageing, 2003.
17. Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010;363:2320-2331.
18. Josefsson A, Berg G, Nordin C, Sydsjo G. Prevalence of depressive symptoms in late pregnancy and postpartum. Acta Obstet Gynecol Scand 2001;80:251-255.
19. Kakko J, Heilig M, Sarman I. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend 2008;96:69-78.
20. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy: effects and management. Obstet Gynecol Clin North Am 1998;25:139-151.
21. Kandall SR. Treatment options for drug-exposed infants. NIDA Research Monograph 1995;149:78-99.
22. Kreek MJ. Medical safety and side effectsofmethadoneintolerant individuals. JAMA 1973;223:665-668.
23. Lacroix I, Berrebi A, Chaumerliac C, et al. Buprenorphine in pregnant opioid-dependent women: first results of a prospective study. Addiction 2004;99:209-214.
24. Lejeune C, Simmat-Durand L, Gourarier L, Aubisson S. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenorphine substitution. Drug Alcohol Depend 2006;82:250-257.
25. Lintzeris N, Clark N, Winstock A, et al. National Clinical Guidelines and Procedures for the Use of Buprenorphine in the Maintenance Treatment of Opioid Dependence. Canberra, Australia: National Drug Strategy, 2006.
26. Lintzeris N, Mitchell TB, Bond AJ, Nestor L, Strang J. Pharmacodynam-ics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients. Drug Alcohol Depend 2007;91:187-194.
27. Llewellyn-Jones D. Fundamentals of Obstetrics and Gynecology. Barcelona, Spain: Mosby, 1999.
28. Longwell B, Kestler RJ, Cox TJ. Side effects in methadone patients: a survey of self-reported complaints. Int J Addict 1979;14:485-494.
29. Lyons-Ruth K, Zoll D, Connell D, Grunebaum HU. The depressed mother and her one-year-old infant: environment, interaction, attachment, and infant development. New Dir Child Dev 1986:61-82.
30. Mello NK, Mendelson JH, Kuehnle JC. Buprenorphine effects on human heroin self-administration: an operant analysis. J Pharmacol Exp Ther 1982;223:30-39.
31. Merrick J, Merrick E, Morad M, Kandel I. Fetal alcohol syndrome and its long-term effects. Minerva Pediatr 2006;58:211-218.
32. MIMS Australia. MIMS Annual 2002: Australian Edition. Crows Nest, New South Wales: MIMS Australia, 2001.
33. Mitchell TB, White JM, Somogyi AA, Bochner F. Comparative pharma-codynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence. Drug Alcohol Depend 2003;72:85-94.
34. Moehler E, Brunner R, Wiebel A, Reck C, Resch F. Maternal depressive symptoms inthe postnatal period are associated with long-term impairment of mother-child bonding. Arch Womens Ment Health 2006;9:273-278.
35. Murray L. The impact of postnatal depression on infant development. J Child Psychol Psych All Discipl 1992;33:543-561.
36. NHMRC. Australian Alcohol Guidelines: Health Risks and Benefits. Canberra, Australia: National Health and Medical Research Council, 2001.
37. Niebyl Jr. Clinical practice: nausea and vomiting in pregnancy. N Engl J Med 2010;363:1544-1550.
38. SAPPWG. South Australian Perinatal Practice Guidelines. Adelaide, Australia: The South Australian Department of Health, 2005.
39. Spitzer RL, Kroenke K, Linzer M, et al. Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study.JAMA1995;274:1511-1517.
40. Sullivan S. Cannabinoid hyperemesis. Can J Gastroenterol 2010;24:284-285.
41. Ward J, Mattick RP, Hall W. The use of methadone during maintenance treatment: pharmacology, dosage and treatment outcome. In: Ward J, Mattick RP, Hall Weds. Methadone Maintenance and Other Replacement Opioid Therapies. Amsterdam, the Netherlands: Harwood Academic Publishers, 1998:205-238.
42. Zuspan FP, Gumpel JA, Mejia-Zelaya A, Madden J, Davis R. Fetal stress from methadone withdrawal. Am J Obstet Gynecol 1975;122:43-46.